Access cutting-edge hemophilia a treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access hemophilia a specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hemophilia a treatment provided free
WP44714 is a Phase I/II, open-label, non-randomized, global, multicenter trial consisting of two parts: * Part 1 is a multiple-ascending dose (MAD) study in adult and adolescent male participants with severe or moderate hemophilia A with or without factor VIII (FVIII) inhibitors. * Part 2 is a multiple-dose study in pediatric male participants with severe or moderate hemophilia A with or without FVIII inhibitors. The overall aim of the study is to investigate the safety, tolerability, pharmaco
Sponsor: Hoffmann-La Roche
Check if you qualify for this hemophilia a clinical trial in Indianapolis, IN
If you're searching for hemophilia a treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hemophilia a specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.